Medpage Today on MSN2d
Which High-Risk Patients Should Get the RSV Vaccine?The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced new preliminary data for AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) in adults aged 18-49 at increased risk for ...
Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...
Medpage Today on MSN2d
Real-World Data on the RSV Vaccine for Older AdultsRegarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
Investor's Business Daily on MSN14d
GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The SkidsGSK stock crumbled on Wednesday after vaccine sales tumbled, leading to a third-quarter miss. Revenue from RSV shot Arexvy ...
The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...
Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...
RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...
GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...
Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...
With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback